G6PD and pituitary tumor: For pituitary tumors, miR-1-3p was able to inhibit NADPH production and glycolytic processes in pituitary tumor cells by targeting G6PD, causing inhibition of proliferation and promotion of apoptosis (Fig. 3) (Table 1) [149].